Corona's uncontrollable pace has created a serious crisis in the country. All the efforts taken by the government are inadequate and the patients of Corona are continuously dying. Meanwhile, the Drugs Controller General of India (DCGI) has approved the emergency use of 'Virafin' of Ahmedabad-based drugmaker Zydus Cadila.
Zydus Cadila stated that Pegylated Interferon alpha-2b, 'Virafin' is greatly helped by emergency use in adults with Covid-19 infection. Zydus Cadila said that 'Virafin' will be provided to hospitals.
Earlier, Zydus Cadila had sought approval from the Drug Controller General of India for the treatment of Covid-19. The company had said that the drug Pegylated Interferon Alpha 2b or PegiHep has proved to be effective 91.15 percent. The initial third-phase human trial yielded promising results from the drug. Interim results indicated that timely delivery of the drug may help patients recover more quickly and avoid the complication seen in the advanced stages of the disease.
Pegylated Interferon Alpha 2b or PegiHep is an approved drug in India and has been re-formulated for the treatment of Covid-19. Preliminary results of Phase III human testing showed that drug use cured 91.15 percent of Covid-19 patients within 7 days and their positive corona test report was negative in the RT-PCR test.
The company claims that Pegylated Interferon Alpha 2b or PegiHep is a single-dose drug. With single-dose medicine, treatment will be less cumbersome and more economical for the patients. According to the company, during the test, drug-dependent patients also had less need for oxygen support. This makes it clear that the drug can control shortness of breath, which is a major challenge in the treatment of Covid-19.
"We are excited by the results of the Phase III trial of Pegylated Interferon Alpha 2b which confirmed the possibility of reducing the impact of the virus on the timely use of the disease," said Shravil Patel of Cadila Healthcare. In December 2020, the company was permitted the drug regulator to start Phase III human trials on Covid-19 patients.
ASEAN Summit: PM Modi met Japan's new Prime Minister Ishiba, discussed cooperation in various fields
PM Narendra Modi met Japan's new PM Shigeru Ishiba in Laos on Thursday. This is the first meeting
In the last 24 hours, 13,166 new cases of the corona were found in the country, 26,968 patients w
Elections are over in 5 states including UP, Punjab, Uttarakhand, Manipur, Goa. After two days i.
The Joint Parliamentary Committee constituted for detailed deliberations on the One Nation, One E
The Common University Entrance Test (CUET) is being conducted by the National Testing Agency (NTA
In IPL 2024, Royal Challengers Bangalore (RCB) will face Kolkata Knight Riders on Friday. Apart f
There is a lot of uproar in Salman Khan's show 'Bigg Boss 18' at this time. It has been 10 days s
Flood situation persists in Manipur and Assam due to continuous rains after cyclone Remal. In Man
Congress MP Adhir Ranjan Chowdhury, who was again embroiled in controversies after saying the wor
The last match of the five-match Test series between India and England (IND vs ENG 5th Test) is b
